Heron Therapeuti
HRTX
$0.36-4.12%
End of day · as of Oct 17, 2026, 2:00 AM ET
Mkt cap
$332.59M
EV/Sales
1.96
P/E ratio
N/A
FY2025 Revenue
$154.90M
EPS (H1 2026)
$-0.07
Gross Margin (FY2025)
73.31%
Profit Margin (FY2025)
-13.04%
Beta
1.17
Div yield
N/A
Sector
Healthcare
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
Latest reported HRTX revenue for 2025-12-31 was $154.9M. Net income was -$20.2M. Revenue was up 7.4% from 2024-12-31 to 2025-12-31. HRTX currently screens at market cap $332.6M.
Use this HRTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full HRTX income, balance, and cash tables.
Heron Therapeuti (HRTX) is a biotechnology company in the Healthcare sector.
Latest cached Heron Therapeuti (HRTX) revenue for Dec 31, 2025 was $154.9M. Net income was -$20.2M. Statements: https://lician.com/financials/hrtx
Heron Therapeuti (HRTX) market capitalization is $332.6M on the latest cached snapshot.
Heron Therapeuti (HRTX) cached previous close $0.38; day range $0.36 – $0.38; volume 1,725,606. Session quote: https://lician.com/quote/hrtx
Heron Therapeuti (HRTX) latest cached earnings event is "HRTX earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached HRTX filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/hrtx